|
[1]
|
J. M. Ritter, L. D. Lewis and T. G. K. Mant, “A Textbook of Clinical Pharmacology,” 4th Edition, Arnold Ltd., London, 1999.
|
|
[2]
|
“The United States Pharmacopoeia,” 27th Edition, “Na-tional Formulary 22,” Asian Edition, Rockville, 2004.
|
|
[3]
|
T. Uno, N. Yasui-Furukori, T. Takahata, K. Sugawara and T. Tateishi, “Determination of Lansoprazole and Two of its Metabolites by Liquid-Liquid Extraction and Automated Column Switching High-Performance—Liquid Chromatography: Application to Measuring CYP2C19 Activity,” Journal of Chromatography B, Vol. 816, No. 1-2, February 2005, pp. 309-314.
|
|
[4]
|
H. Katsuki, A. Hamada, C. Nakamura, K. Arimori and M. Nakano, “High-Performance Liquid Chromatographic Assay for the Simultaneous Determination of Lansopra-zole Enantiomers and Metabolites in Human Liver Mi-crosomes,” Journal of Chromatography B, Vol. 757, No. 1, pp. 127-133.
|
|
[5]
|
Z. A. El-Sheref, A. O. Mohamad, M. G. El-Baradicy and M. F. El-Tarras, “Reversed-Phase High Performance Liquid Chromatographic Method for the Determination of Lansoprazole, Omeprazole and Pantoprazole Sodium Sesquihydrate in Presence of Their Acid-Induced Degra-dation Products,” Chemical and Pharmaceutical Bulletin, Vol. 54, No. 6, June 2006, pp. 814-818.
|
|
[6]
|
M. Miura, H. Tada and T. Suzuki, “Simultaneous Deter-mination of Lansoprazole Enantiomers and their Metabo-lites in Plasma by Liquid Chromatography with Sol-id-Phase Extraction,” Journal of Chromatography B, Vol. 804, No. 2, May 2004, pp. 389-395.
|
|
[7]
|
A. Avgerinos, T. Karidas, C. Potsides and S. Axarlis, “Determination of Lansoprazole in Biological Fluids and Pharmaceutical Dosage by HPLC,” European Journal of Drug Metabolism and Pharmacokinetics, Vol. 23, No. 2, 1998, pp. 329-332.
|
|
[8]
|
M. F. Tutunji, A. M. Qaisi, B. El-Eswed, L. F. Tutunji, “An in Vitro Investigation on Acid Catalyzed Reactions of Proton Pump Inhibitors in the Absence of an Electrophile, International Journal of Pharmaceutics, Vol. 323, No. 1-2, October 2006, pp. 110-116.
|
|
[9]
|
A. Radi, “Adsorptive Stripping Square-Wave Voltamme-tric Study of the Degradation of Lansoprazole in Aqueous Solutions, Microchemical Journal, Vol. 73, No. 3, De-cember 2002, pp. 349-354.
|
|
[10]
|
C. Yardimci and N. Ozaltin, “Electrochemical Studies and Differential Pulse Polarographic Analysis of Lansoprazole in Pharmaceuticals,” The Analyst, Vol. 126, No. 3, March 2001, pp. 361-366.
|
|
[11]
|
N. Rahman, Z. Bano, S. N. Azmi, M. Kashif, “A Kinetic Spectrophotometric Method for the Determination of Lansoprazole in Pharmaceutical Formulations,” Journal of the Serbian Chemical Society, Vol. 71, No. 10, 2006, pp. 1107-1120.
|
|
[12]
|
D. Yeniceli, D. Dogrukol-Ak and M. Tuncel, “Determi-nation of Lansoprazole in Pharmaceuticals Capsules by Flow Injection Analysis Using UV-Detection,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 36, No. 1, September 2004, pp. 145-148.
|
|
[13]
|
N. Ozaltin, “Determination of Lansoprazole in Pharma-ceutical Dosage Forms by Two Different Spectroscopic Methods,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 20, No. 3, July 1999, pp. 599-606.
|
|
[14]
|
“Validation of Analytical Procedures: Methodology,” Proceedings of the International Conference on Harmo-nisation of Technical Requirements of Registration of Pharmaceuticals for Human Use, Geneva, 1996.
|